| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
The Hematopathology Section, Laboratory of Anatomic Pathology, Hospital Clínic, Institut dInvestigacions Biomèdiques "August Pi i Sunyer" (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain [S. B., F. T., M. P., X. P., L. H., S. H., P. L. F., D. C., E. C.], and Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands [M. v. L.]
The BMI-1 gene is a putative oncogene belonging to the Polycomb group family that cooperates with c-myc in the generation of mouse lymphomas and seems to participate in cell cycle regulation and senescence by acting as a transcriptional repressor of the INK4a/ARF locus. The BMI-1 gene has been located on chromosome 10p13, a region involved in chromosomal translocations in infant leukemias, and amplified in occasional non-Hodgkins lymphomas (NHLs) and solid tumors. To determine the possible alterations of this gene in human malignancies, we have examined 160 lymphoproliferative disorders, 13 myeloid leukemias, and 89 carcinomas by Southern blot analysis and detected BMI-1 gene amplification (3- to 7-fold) in 4 of 36 (11%) mantle cell lymphomas (MCLs) with no alterations in the INK4a/ARF locus. BMI-1 and p16INK4a mRNA and protein expression were also studied by real-time quantitative reverse transcription-PCR and Western blot, respectively, in a subset of NHLs. BMI-1 expression was significantly higher in chronic lymphocytic leukemia and MCL than in follicular lymphoma and large B cell lymphoma. The four tumors with gene amplification showed significantly higher mRNA levels than other MCLs and NHLs with the BMI-1 gene in germline configuration. Five additional MCLs also showed very high mRNA levels without gene amplification. A good correlation between BMI-1 mRNA levels and protein expression was observed in all types of lymphomas. No relationship was detected between BMI-1 and p16INK4a mRNA levels. These findings suggest that BMI-1 gene alterations in human neoplasms are uncommon, but they may contribute to the pathogenesis in a subset of malignant lymphomas, particularly of mantle cell type.
This article has been cited by other articles:
![]() |
M. L. Fulcher, S. E. Gabriel, J. C. Olsen, J. R. Tatreau, M. Gentzsch, E. Livanos, M. T. Saavedra, P. Salmon, and S. H. Randell Novel human bronchial epithelial cell lines for cystic fibrosis research Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L82 - L91. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hartmann, V. Fernandez, V. Moreno, J. Valls, L. Hernandez, F. Bosch, P. Abrisqueta, W. Klapper, M. Dreyling, E. Hoster, et al. Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue J. Clin. Oncol., October 20, 2008; 26(30): 4966 - 4972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohty, R. M. Szydlo, A. S. M. Yong, J. F. Apperley, J. M. Goldman, and J. V. Melo Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia Blood, September 1, 2008; 112(5): 2163 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, X. Ma, J. Wang, J. Koontz, M. Nucci, and J. Sklar Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival PNAS, December 11, 2007; 104(50): 20001 - 20006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Datta, M. J. Hoenerhoff, P. Bommi, R. Sainger, W.-J. Guo, M. Dimri, H. Band, V. Band, J. E. Green, and G. P. Dimri Bmi-1 Cooperates with H-Ras to Transform Human Mammary Epithelial Cells via Dysregulation of Multiple Growth-Regulatory Pathways Cancer Res., November 1, 2007; 67(21): 10286 - 10295. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Rajasekhar and M. Begemann Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective Stem Cells, October 1, 2007; 25(10): 2498 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wiederschain, L. Chen, B. Johnson, K. Bettano, D. Jackson, J. Taraszka, Y. K. Wang, M. D. Jones, M. Morrissey, J. Deeds, et al. Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis Mol. Cell. Biol., July 1, 2007; 27(13): 4968 - 4979. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kienle, T. Katzenberger, G. Ott, D. Saupe, A. Benner, H. Kohlhammer, T. F.E. Barth, S. Holler, J. Kalla, A. Rosenwald, et al. Quantitative Gene Expression Deregulation in Mantle-Cell Lymphoma: Correlation With Clinical and Biologic Factors J. Clin. Oncol., July 1, 2007; 25(19): 2770 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hosen, T. Yamane, M. Muijtjens, K. Pham, M. F. Clarke, and I. L. Weissman Bmi-1-Green Fluorescent Protein-Knock-In Mice Reveal the Dynamic Regulation of Bmi-1 Expression in Normal and Leukemic Hematopoietic Cells Stem Cells, July 1, 2007; 25(7): 1635 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohty, A. S. M. Yong, R. M. Szydlo, J. F. Apperley, and J. V. Melo The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia Blood, July 1, 2007; 110(1): 380 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pinyol, S. Bea, L. Pla, V. Ribrag, J. Bosq, A. Rosenwald, E. Campo, and P. Jares Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis Blood, June 15, 2007; 109(12): 5422 - 5429. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Salaverria, A. Zettl, S. Bea, V. Moreno, J. Valls, E. Hartmann, G. Ott, G. Wright, A. Lopez-Guillermo, W. C. Chan, et al. Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression-Based Proliferation Signature J. Clin. Oncol., April 1, 2007; 25(10): 1216 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Scott, J. Gil, E. Hernando, J. Teruya-Feldstein, M. Narita, D. Martinez, T. Visakorpi, D. Mu, C. Cordon-Cardo, G. Peters, et al. Role of the chromobox protein CBX7 in lymphomagenesis PNAS, March 27, 2007; 104(13): 5389 - 5394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dutton, C. B. Woodman, M. B. Chukwuma, J. I. K. Last, W. Wei, M. Vockerodt, K. R. N. Baumforth, J. R. Flavell, M. Rowe, A. M. R. Taylor, et al. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells Blood, March 15, 2007; 109(6): 2597 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Costa, K. Le Blanc, and B. Brodin Concise Review: Cancer/Testis Antigens, Stem Cells, and Cancer Stem Cells, March 1, 2007; 25(3): 707 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mestre-Escorihuela, F. Rubio-Moscardo, J. A. Richter, R. Siebert, J. Climent, V. Fresquet, E. Beltran, X. Agirre, I. Marugan, M. Marin, et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas Blood, January 1, 2007; 109(1): 271 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Silva, J. M. Garcia, C. Pena, V. Garcia, G. Dominguez, D. Suarez, F. I. Camacho, R. Espinosa, M. Provencio, P. Espana, et al. Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas Clin. Cancer Res., December 1, 2006; 12(23): 6929 - 6936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tateishi, M. Ohta, F. Kanai, B. Guleng, Y. Tanaka, Y. Asaoka, M. Tada, M. Seto, A. Jazag, L. Lianjie, et al. Dysregulated Expression of Stem Cell Factor Bmi1 in Precancerous Lesions of the Gastrointestinal Tract Clin. Cancer Res., December 1, 2006; 12(23): 6960 - 6966. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-B. Song, M.-S. Zeng, W.-T. Liao, L. Zhang, H.-Y. Mo, W.-L. Liu, J.-Y. Shao, Q.-L. Wu, M.-Z. Li, Y.-F. Xia, et al. Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells. Cancer Res., June 15, 2006; 66(12): 6225 - 6232. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marce, O. Balague, L. Colomo, A. Martinez, S. Holler, N. Villamor, F. Bosch, G. Ott, A. Rosenwald, L. Leoni, et al. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin. Cancer Res., June 15, 2006; 12(12): 3754 - 3761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pscherer, J. Schliwka, K. Wildenberger, A. Mincheva, C. Schwaenen, H. Dohner, S. Stilgenbauer, and P. Lichter Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma FASEB J, June 1, 2006; 20(8): 1188 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nowak, K. Kerl, D. Fehr, C. Kramps, C. Gessner, K. Killmer, B. Samans, B. Berwanger, H. Christiansen, and W. Lutz BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res., January 1, 2006; 34(6): 1745 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kasugai, H. Tagawa, Y. Kameoka, Y. Morishima, S. Nakamura, and M. Seto Identification of CCND3 and BYSL as Candidate Targets for the 6p21 Amplification in Diffuse Large B-Cell Lymphoma Clin. Cancer Res., December 1, 2005; 11(23): 8265 - 8272. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fernandez, E. Hartmann, G. Ott, E. Campo, and A. Rosenwald Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response Pathways J. Clin. Oncol., September 10, 2005; 23(26): 6364 - 6369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Melnick, K. Adelson, and J. D. Licht The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice? J. Clin. Oncol., June 10, 2005; 23(17): 3957 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rubio-Moscardo, J. Climent, R. Siebert, M. A. Piris, J. I. Martin-Subero, I. Nielander, J. Garcia-Conde, M. J. S. Dyer, M. J. Terol, D. Pinkel, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome Blood, June 1, 2005; 105(11): 4445 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Raaphorst Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R93 - R100. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hernandez, S. Bea, M. Pinyol, G. Ott, T. Katzenberger, A. Rosenwald, F. Bosch, A. Lopez-Guillermo, J. Delabie, D. Colomer, et al. CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus Cancer Res., March 15, 2005; 65(6): 2199 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. PARDAL, A.V. MOLOFSKY, S. HE, and S.J. MORRISON Stem Cell Self-Renewal and Cancer Cell Proliferation Are Regulated by Common Networks That Balance the Activation of Proto-oncogenes and Tumor Suppressors Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 177 - 185. [Abstract] [PDF] |
||||
![]() |
G. Chen, W. Zeng, A. Miyazato, E. Billings, J. P. Maciejewski, S. Kajigaya, E. M. Sloand, and N. S. Young Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities Blood, December 15, 2004; 104(13): 4210 - 4218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lund and M. van Lohuizen Epigenetics and cancer Genes & Dev., October 1, 2004; 18(19): 2315 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kohlhammer, C. Schwaenen, S. Wessendorf, K. Holzmann, H. A. Kestler, D. Kienle, T. F. E. Barth, P. Moller, G. Ott, J. Kalla, et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions Blood, August 1, 2004; 104(3): 795 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Dimri, J.-L. Martinez, J. J. L. Jacobs, P. Keblusek, K. Itahana, M. van Lohuizen, J. Campisi, D. E. Wazer, and V. Band The Bmi-1 Oncogene Induces Telomerase Activity and Immortalizes Human Mammary Epithelial Cells Cancer Res., August 15, 2002; 62(16): 4736 - 4745. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mertens, S. Wolf, P. Schroeter, C. Schaffner, H. Dohner, S. Stilgenbauer, and P. Lichter Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia Blood, May 13, 2002; 99(11): 4116 - 4121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Otte and M. van Lohuizen Correspondence re: S. Bea et al., BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphomas. Cancer Res., 61: 2409-2412, 2001 Cancer Res., January 1, 2002; 62(2): 618 - 618. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |